Detection of biomarkers from exhaled breath
AssigneeThe Regents of the University of California
InventorsDan M. COOPER, Eric O. Potma, Kim Lu
Life of this patent
Estimating the term…
Abstract
The technology relates to devices and methods thereof for the detection of one or more biomarkers from a user's exhaled breath. In one embodiment, the present invention provides a device comprising a metered dose inhaler, and a sensor that detects one or more biomarkers comprising HFA, CO2, and NO. In another embodiment, the device detects HFA, CO2 and NO simultaneously by photoacoustic spectroscopy. In another embodiment, the device may be used as part of an overall treatment regimen for asthma or COPD.
Claims28
A device, comprising:
- a sensor that detects one or more biomarkers from a user's exhaled breath by photoacoustic spectroscopy (PAS).
A method of treating a pulmonary disease in a subject, comprising:
- providing a device comprising a metered dose inhaler and a sensor that detects one or more biomarkers from a user's exhaled breath;
- and
- treating the pulmonary disease in the subject.
A method of increasing the effectiveness of measurement of active medication being administered to a patient, comprising:
- providing a patient being currently treated by medication;
- and
- managing the efficacy of the medication being administered by using a device comprising a metered dose inhaler and a sensor that detects one or more biomarkers from a user's exhaled breath.
Dependencies are inferred from the claim text.